• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

migraine - Articles and news items

Eli Lilly to aquire pain biotech CoLucid for $960 million

Industry news / 19 January 2017 / Niamh Marriott, Digital Editor

This transaction will be acting to enhance Lilly’s existing portfolio in pain management for migraine, while adding a potential near-term launch…

AMG 334 significantly reduces monthly migraine days in study

Industry news / 9 June 2016 / Victoria White, Digital Content Producer

Novartis has announced positive first results from a Phase II investigating the efficacy and safety of AMG 334 (erenumab) in chronic migraine prevention…